Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Measurement Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Safety of integrated mass drug administration of azithromycin, albendazole and ivermectin versus standard treatment regimens: a cluster-randomised trial in Ethiopia.

McPherson S, Tafese G, Tafese T, et al. EClinicalMedicine. 2023;
Download PDF
Publication

NTD programmes hold the key to universal health coverage and better climate and emergency responses.

Fall I, Ducker C, Solomon A. PLOS global public health. 2023;
Download PDF
Publication

Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin.

Gnimavo R, Fajloun F, Al-Bayssari C, et al. PLoS neglected tropical diseases. 2023; 17 (5) : 1-19.
Download PDF
Publication

'We do not rush to the hospital for ordinary wounds (suḷu tuvāla)': A qualitative study on the early clinical manifestations of cutaneous leishmaniasis and associated health behaviours in rural Sri Lanka.

Gunasekara S, Wickramasinghe N, Agampodi S, et al. PLoS neglected tropical diseases. 2023; 17 (5) : e0010939.
Download PDF
Publication

The development, implementation, and evaluation of an optimal model for the case detection, referral, and case management of Neglected Tropical Diseases

Godwin-Akpan TG, Chowdhury S, Rogers EJ, et al. Public Library of Science (PLoS). PLOS ONE. 2023; 18 (5) : 1-21.
Download PDF
Publication

Understanding factors responsible for the slow decline of soil-transmitted helminthiasis following seven rounds of annual mass drug administration (2012–2018) among school children in endemic counties of Kenya: A mixed method study

Masaku J, Okoyo C, Araka S, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (5) : e0011310.
Download PDF
Publication

Sudden emergence and spread of cutaneous larva migrans in Sudan: A case series calls for urgent actions

Ahmed A, Hemaida MA, Hagelnur AA, et al. Elsevier BV. IDCases. 2023;
Download PDF
Publication

Lymphatic Filariasis Elimination in Kerala: A Success Story

Meenakshy V., Viswan K A., Sharma S. N. , et al. Journal of Communicable Diseases. 2023; 55 (1) : 91-97.
Download PDF
Publication

Unlocking the potential of snake venom-based molecules against the malaria, Chagas disease, and leishmaniasis triad

Almeida JR, Gomes A, Mendes B, et al. Elsevier BV. International Journal of Biological Macromolecules. 2023;
Download PDF
Publication

COVID-19 in patients with paracoccidioidomycosis

de Macedo PM, Benko LMP, Falcão EMM, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (5) : 1-8.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 209
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2026 InfoNTD